Pauline A. Swift

ORCID: 0000-0003-2568-9871
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Sodium Intake and Health
  • Chronic Kidney Disease and Diabetes
  • Diabetes Treatment and Management
  • Dialysis and Renal Disease Management
  • SARS-CoV-2 and COVID-19 Research
  • Erythropoietin and Anemia Treatment
  • Blood Pressure and Hypertension Studies
  • Iron Metabolism and Disorders
  • Long-Term Effects of COVID-19
  • Renal function and acid-base balance
  • Electrolyte and hormonal disorders
  • Hormonal Regulation and Hypertension
  • Potassium and Related Disorders
  • Cardiovascular and exercise physiology
  • Renal Diseases and Glomerulopathies
  • Vaccine Coverage and Hesitancy
  • Renal and Vascular Pathologies
  • Intensive Care Unit Cognitive Disorders
  • Diabetes Management and Research
  • Ion Transport and Channel Regulation
  • Influenza Virus Research Studies
  • Central Venous Catheters and Hemodialysis
  • COVID-19 and healthcare impacts
  • Diet and metabolism studies

Epsom and St Helier University Hospitals NHS Trust
2014-2025

National Health Service
2020-2024

University of Oxford
2023

King's College Hospital
2022

St George’s University Hospitals NHS Foundation Trust
2021

Guy's and St Thomas' NHS Foundation Trust
2021

University College London
2021

Salford Royal NHS Foundation Trust
2021

Royal Free London NHS Foundation Trust
2021

St Helier Hospital
2008-2020

Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains full-length spike glycoprotein prototype strain plus Matrix-M adjuvant, showed was safe and associated with robust immune response in healthy adult participants. Additional were needed regarding efficacy, immunogenicity, safety this larger population.In phase 3, randomized, observer-blinded, placebo-controlled...

10.1056/nejmoa2107659 article EN New England Journal of Medicine 2021-06-30

High blood pressure and proteinuria are the major risk factors for cardiovascular renal disease. In black individuals, there is an increased of hypertension, stroke, heart failure, kidney There no controlled studies effects reducing salt intake on urine protein excretion in individuals. Therefore, aim our study was to determine modest restriction nondiabetic hypertensive subjects. The randomized, double blind, placebo controlled. After run-in periods their usual diet reduced salt,...

10.1161/01.hyp.0000172662.12480.7f article EN Hypertension 2005-06-28
Seth Toback Eva Galiza Catherine Cosgrove James Galloway Anna L. Goodman and 95 more Pauline A. Swift Sankarasubramanian Rajaram Alison Graves-Jones Jonathan M. Edelman Fiona Burns Angela M. Minassian Iksung Cho Lakshmi Kumar Joyce S. Plested Elizabeth Rivers Andreana Robertson Filip Dubovsky Greg Glenn Paul T. Heath Roy L. Soiza Robin Brittain-Long Chiara Scicluna Carole Edwards Lynn MacKay Mariella D'Allesandro Amy Nicol Karen A. Norris Sandra Mann H. SHERWOOD LAWRENCE Ruth A. Valentine Marianne Elizabeth Viljoen Carol Pretswell Helen Nicholls Imrozia Munsoor Agnieszka Meyrick Christina Kyriakidou Shalini Iyengar Arham Jamal Nick Richards Helen Price Bridie Rowbotham Danielle Bird Karen Smith Olga Littler Kirsty Fielding Anna Townsend-Rose Karen Miller Jessica Davis Alison Elliot-Garwood Lauren Trottier Paul Edwards Margaret McFarland Orod Osanlou Laura Longshaw J. Stockport Lynne Grundy Katharine Lucy Broad Karen Regan Kim Storton Declan Ryan-Wakeling Brad Wilson Malathy Munisamy John Wright Anil Shenoy Beverley English Lucy Brear Paola Cicconi Marta Boffito Ana Milinkovic Ruth A. Byrne Roya Movahedi Rosalie Housman Naveed Kara Ellen Brown Andrea Cipriani Mary-Jane Attenburrow Katharine Smith Jonathan Packham Geoff Sparrow Richard Smith Josephine M. Rosier Khalid Saja Nyasha Nago Brian Camilleri Anita Immanuel Michael R. Hamblin Rawlings Osagie Mahalakshmi Mohan H. Floyd Suzanne Goddard Sanjay Mutgi John P. Evans Sean McKeon Neringa Vilimiene Rosavic Chicano Rachel Hayre Alice Pandaan Catherine Henshall Sonia Serrano Andrea Mazzella

10.1016/s2213-2600(21)00409-4 article EN other-oa The Lancet Respiratory Medicine 2021-11-17

Abstract Background The recombinant protein-based vaccine, NVX-CoV2373, demonstrated 89.7% efficacy against coronavirus disease 2019 (COVID-19) in a phase 3, randomized, observer-blinded, placebo-controlled trial the United Kingdom. protocol was amended to include blinded crossover. Data end of are reported. Methods Adults aged 18–84 years received 2 doses NVX-CoV2373 or placebo (1:1) and were monitored for virologically confirmed mild, moderate, severe COVID-19 (onset from 7 days after...

10.1093/cid/ciac803 article EN cc-by-nc-nd Clinical Infectious Diseases 2022-10-10

The cardiovascular and kidney benefits of sodium-glucose co-transporter-2 (SGLT2) inhibitors in people with chronic disease (CKD) are well established. implementation updated SGLT2 inhibitor guidelines prescribing the real-world CKD population remains largely unknown.

10.1016/j.eclinm.2024.102426 article EN cc-by-nc-nd EClinicalMedicine 2024-01-21

Observational studies suggest sodium-glucose co-transporter 2 (SGLT2) inhibitor kidney outcome trials are not representative of the broader population people with chronic disease (CKD). However, there limited data on generalizability to those without co-existing type diabetes (T2D), and representativeness Study Heart Kidney Protection Empagliflozin (EMPA-KIDNEY) trial has been adequately explored. We hypothesized that SGLT2 more T2D than without, EMPA-KIDNEY is previous trials.

10.1093/ndt/gfae071 article EN cc-by Nephrology Dialysis Transplantation 2024-03-22

The objective was to assess the role of office and ambulatory blood pressure (BP) on development end-stage renal disease (ESRD) in nondiabetic chronic failure.Seventy-nine patients [mean age 57 (standard deviation 11) years, 47 men, BMI 28 (4), BP 151 (25)/92 (14) mmHg, estimated glomerular filtration rate ml/min per 1.73 m3] were included. causes nephrosclerosis (n = 33), glomerulonephritis 19), interstitial 12) others 15). average follow-up 44 months (range 9-72 months). primary outcome a...

10.1097/hjh.0b013e328333fe4d article EN Journal of Hypertension 2010-02-13

ABSTRACT Background Non-anaemic iron deficiency is highly prevalent in people living with chronic kidney disease (CKD) but underdiagnosed and undertreated, especially earlier stages of CKD. A multicentre trial assessing the effect intravenous supplementation iron-deficiency not anaemic CKD included a qualitative sub-study that aimed to explore patient experience psychosocial impact deficiency, therapeutic intervention (intravenous exercise). Methods Semi-structured interviews were conducted...

10.1093/ckj/sfae433 article EN cc-by Clinical Kidney Journal 2025-01-01

Accurately identifying cases of chronic kidney disease (CKD) from primary care data facilitates the management patients, and is vital for surveillance research purposes. Ontologies provide a systematic transparent basis clinical case definition can be used to identify codes relevant all aspects CKD its diagnosis. We routinely collected Royal College General Practitioners Research Surveillance Centre. A domain ontology was created presented in Ontology Web Language (OWL). The identification...

10.1186/s12882-018-0882-9 article EN cc-by BMC Nephrology 2018-04-10

Abstract To investigate the symptoms of SARS-CoV-2 infection, their dynamics and discriminatory power for disease using longitudinally, prospectively collected information reported at time occurrence. We have analysed data from a large phase 3 clinical UK COVID-19 vaccine trial. The alpha variant was predominant strain. Participants were assessed infection via nasal/throat PCR recruitment, vaccination appointments, when symptomatic. Statistical techniques implemented to infer estimates...

10.1017/s0950268824000037 article EN cc-by-nc-nd Epidemiology and Infection 2024-01-01

Plasma sodium is increased following each meal containing salt. There an increasing interest in the effects of plasma concentration, and it has been suggested that may have direct on blood pressure (BP) possibly influences endothelial function. Experimental increases concentration rapidly raise BP even when extracellular volume falls. Ten patients with end-stage renal failure established haemodialysis were studied during first 2 h dialysis without fluid removal this period. They randomized...

10.1093/ndt/gft081 article EN Nephrology Dialysis Transplantation 2013-06-05

<h3>ABSTRACT</h3> High salt intake is now endemic worldwide. It contributes to the generation and maintenance of high blood pressure, which biggest risk factor for global disease. There compelling evidence support reduction in hypertensives a substantial body general population reduce death from cardiovascular In specific diseases such as heart failure chronic kidney disease, guidelines World Health Organization target reduced at 5&nbsp;g daily. Achieving diet that lower has challenges, but...

10.7861/clinmedicine.15-6-585 article EN Clinical Medicine 2015-11-30

ABSTRACT Background Covid-19 vaccines are urgently needed, especially against emerging variants. NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 rS) nanoparticle vaccine containing trimeric full-length SARS-CoV-2 spike glycoprotein and Matrix-M adjuvant. Methods A phase 3, randomized, observer-blinded, placebo-controlled trial was conducted in adults 18-84 years old who received two intramuscular 5-µg doses, 21 days apart, of or placebo (1:1) across...

10.1101/2021.05.13.21256639 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-05-14

Patients with chronic kidney disease (CKD) are often iron deficient, even when not anemic. This trial evaluated whether supplementation enhances exercise capacity of nonanemic patients CKD who have iron-deficiency.Prospective, multicenter double-blind randomized controlled nondialysis and iron-deficiency but without anemia (Hemoglobin [Hb] >110 g/l). were assigned 1:1 to intravenous (IV) therapy, or placebo. An 8-week program commenced at week 4. The primary outcome was the mean...

10.1016/j.ekir.2023.05.002 article EN cc-by-nc-nd Kidney International Reports 2023-05-09

Abstract Aim Chronic kidney disease ( CKD ) is increasing in prevalence and associated with cardiovascular events mortality asymptomatic vascular surgery populations. This study aimed to determine the role of stratifying peri‐ postoperative risk for colorectal cancer CRC patients nonmetastatic undergoing elective curative resection. Method Patients diagnosed adenocarcinoma surgical resection between 2006 2011 were identified from a prospectively collated database. Further information on...

10.1111/codi.12665 article EN Colorectal Disease 2014-05-19

Summary Background The safety and immunogenicity profile of COVID-19 vaccines when administered concomitantly with seasonal influenza has not yet been reported. Methods A sub-study on vaccine co-administration was conducted as part the phase 3 randomized trial efficacy NVX-CoV2373. first ∼400 participants meeting main study entry criteria no contraindications to vaccination were invited join sub-study. After randomization in a 1:1 ratio receive NVX-CoV2373 (n=217) or placebo (n=214),...

10.1101/2021.06.09.21258556 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-06-13

Higher serum sodium concentration has been reported to be a risk factor for the development of incident chronic kidney disease (CKD), but its relationship with progression established CKD not investigated. We hypothesised that increased is estimated glomerular filtration rate (eGFR) decline in CKD.This was retrospective cohort study using data collected over 6-year period, baseline obtained during first 2 years. included patients known our renal service who had minimum three blood tests...

10.1007/s40620-018-0541-z article EN cc-by Journal of Nephrology 2018-10-16

Patients on dialysis with frequent comorbidities, advanced age, and frailty, who visit treatment facilities frequently, are perhaps more prone to SARS-CoV-2 infection related death-the risk factors dynamics of which unknown. The aim this study was investigate the hospital outcomes in patients infected SARS-CoV-2.Data 224 hemodialysis between February 29, 2020 May 15, confirmed were analyzed for potential death, using a competing risk-regression model assessed by subdistribution hazards ratio...

10.34067/kid.0004502020 article EN cc-by-nc-nd Kidney360 2020-09-10
Coming Soon ...